CompletedPhase 2NCT02595359
Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis
Studying Endophthalmitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Universidade Federal de Pernambuco
- Principal Investigator
- Rodrigo LiraProf
- Intervention
- Moxifloxacin(drug)
- Enrollment
- 1000 enrolled
- Eligibility
- 50-90 years · All sexes
- Timeline
- 2013 – 2018
Study locations (1)
- UFPE Ophthalmology, Recife, Pernambuco, Brazil
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02595359 on ClinicalTrials.govOther trials for Endophthalmitis
Additional recruiting or active studies for the same condition.
- ACTIVE NOT RECRUITINGNCT07176130Demographics and Clinical Characteristics of Ocular Inflammatory Diseases in SingaporeSingapore National Eye Centre
- RECRUITINGNCT07175311Vascular Changes Associated With Endophthalmitis.Asociación para Evitar la Ceguera en México
- RECRUITINGNCT05432336Complex Ocular Infection, Optimization of Microbiological DiagnosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT05372861Nanopore Sequencing in OphthalmologyMedical University of Graz